SIM-0417
- Generic Name
- SIM-0417
A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19
- First Posted Date
- 2022-08-18
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1208
- Registration Number
- NCT05506176
- Locations
- π¨π³
Hefei First People's Hospital, Hefei, Anhui, China
π¨π³Chongqing Public Health Medical Center, Chongqing, Chongqing, China
π¨π³The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants
- First Posted Date
- 2022-07-27
- Last Posted Date
- 2022-10-03
- Lead Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT05475834
- Locations
- π¨π³
Shandong First Medical University, Jinan, Shandong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath